Boulos S. Nassar

Boulos S. Nassar

Auto-generated profile, based on publicly available information

Boulos S. Nassar

Department of Critical Care Medicine, Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2011 in Science Translational Medicine
Verified
Journal Article
Closed access
LOLynda S. Ostedgaard
Lynda S. Ostedgaard
DMDavid K. Meyerholz
David K. Meyerholz
JCJeng-Haur Chen
Jeng-Haur Chen
APAlejandro A. Pezzulo
Alejandro A. Pezzulo
PKPhilip H. Karp
Philip H. Karp
DSDavid A. Stoltz
David A. Stoltz
A common mutation in human cystic fibrosis, CFTR-ΔF508, results in misprocessed CFTR and a cystic fibrosis–like clinical phenotype in pigs.

1 January 2018 in JACC
Verified
Journal Article
Closed access
UOUchenna R. Ofoma
Uchenna R. Ofoma
SBSuresh Basnet
Suresh Basnet
ABAndrea Berger
Andrea Berger
HKH. Lester Kirchner
H. Lester Kirchner
SGSaket Girotra
Saket Girotra
SPSarah M. Perman
Sarah M. Perman

1 July 2014 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
BNBoulos S. Nassar
Boulos S. Nassar
MVMary S. Vaughan-Sarrazin
Mary S. Vaughan-Sarrazin
LJLan Jiang
Lan Jiang
HRHeather S. Reisinger
Heather S. Reisinger
RBRobert Bonello
Robert Bonello
PCPeter Cram
Peter Cram
Research from JAMA Internal Medicine — Impact of an Intensive Care Unit Telemedicine Program on Patient Outcomes in an Integrated Health Care System

1 February 2016 in Chest
Verified
Journal Article
Closed access
BNBoulos S. Nassar
Boulos S. Nassar
GSGregory A. Schmidt
Gregory A. Schmidt

1 June 2017 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
BNBoulos S. Nassar
Boulos S. Nassar
GSGregory A. Schmidt
Gregory A. Schmidt
The arterial partial pressure of carbon dioxide (PaCO2) is an important parameter in critically ill, mechanically ventilated patients. To limit invasive procedures or for more continuous monitoring of PaCO2, clinicians often rely on venous blood gases, capnography, or transcutaneous monitoring. Each of these has advantages and limitations. Central venous Pco2 allows accurate estimation of PaCO2, differing from it by an amount described by the Fick principle. As long as cardiac output is relatively normal, central venous Pco2 exceeds the arterial value by approximately 4 mm Hg. In contrast, peripheral venous Pco2 is a poor predictor of PaCO2, and we do not recommend using peripheral venous Pco2 in this manner. Capnography offers measurement of the end-tidal Pco2 (PetCO2), a value that is close to PaCO2 when the lung is healthy. It has the advantage of being noninvasive and continuously available. In mechanically ventilated patients with lung disease, however, PetCO2 often differs from PaCO2, sometimes by a large degree, often seriously underestimating the arterial value. Dependence of PetCO2 on alveolar dead space and ventilator expiratory time limits its value to predict PaCO2. When lung function or ventilator settings change, PetCO2 and PaCO2 can vary in different directions, producing further uncertainty. Transcutaneous Pco2 measurement has become practical and reliable. It is promising for judging steady state values for PaCO2 unless there is overt vasoconstriction of the skin. Moreover, it can be useful in conditions where capnography fails (high-frequency ventilation) or where arterial blood gas analysis is burdensome (clinic or home management of mechanical ventilation).

1 November 2017 in Chest
Verified
Journal Article
Closed access
BNBoulos S. Nassar
Boulos S. Nassar
RKRichard Kerber
Richard Kerber